Norwich Clinical Research Medical Device, Pharmaceutical and Nutraceutical Product Development
Norwich Clinical Research Associates (NCRA) is a competitively priced, flexible contract research organization (CRO) with the industry, regulatory, and clinical expertise to see clinical development from all sides of the process. NCRA has been assisting customers with medical device, pharmaceutical and nutraceutical product development since 1994.
Specializing in clinical operations and trial management, monitoring, data management and auditing, NCRA’s knowledgeable staff also provide capable expertise in medical monitoring, product development consulting, biostatistical, and medical / technical writing services.
Focused CRO solutions and integrated service modules
At NCRA, your projects receive the commitment they deserve. Focused solutions work for you, whether we are conducting parts of, or whole, projects for your products development. NCRA’s full-service multi-faceted teams and integrated service modules facilitate making us your most cost-effective partner.
Our clients indicate that our stability, proficiency and expertise put NCRA ahead of the competition. Approximately 67% of our contracts are repeat business from our clients.
Conducting, reporting and outsourcing for clinical research projects
Norwich Clinical Research Associates will provide rapid, accurate, cost-effective services to the pharmaceutical, medical device and nutraceutical industries, meeting the industries’ specific outsourcing needs for quality clinical research. NCRA is dedicated to conduct and report clinical research that meets all applicable regulations and the international conference on harmonization’s (ICH) good clinical practice (GCP) E6 guideline.
Our primary product is the completion of clinical research projects on time at a competitive cost.
NCRA provides client-specific assistance for all segments of clinical trials:
- Product development consultants
- Medical monitors
- Clinical research associates
- Data management and database development / programming professionals
- GCP and other auditing professionals
- Medical / technical writers
- Regulatory consultants
Qualified, supplemental resources and services
NCRA is a CRO – a full-service contract research organization and a critical resource organization, providing valuable strategic and tactical advice, product development and marketing strategy consultations. NCRA brings you qualified, supplemental resources and services that you need quickly when you require them. We provide accurate, cost-effective services meeting the industry’s specific outsourcing needs for quality clinical research.
Small or large clinical trials
Specialising in Phase I-IV pharmaceutical and 510(k) through PMA clinical studies for product development, NCRA conducts in entirety small to large clinical trials from protocol design to completion of the final reports for regulatory submission. Experienced in preparation and completion of FDA regulatory applications, we are a valuable asset to virtual and start-up companies.
Products and Services
FDA Approves Beech Tree Labs’ Recurrent Oral Herpes Infections IND Application – Another Successful Collaboration Milestone for NCRA and BTL
Beech Tree Labs has announced that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections. The study will be a 210 patient, multi-site, placebo-controlled trial and is anticipated to begin later thiRead more
By Glenda Guest, vice president, Norwich Clinical Research Associates (NCRA) While the title of the new guidance from FDA is 'Investigator Responsibilities', in reality sponsors also have obligations since securing investigator compliance with applicable regulations is one of theRead more
Beech Tree Labs, Inc., has announced that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections. In the US outbreaks of seasonal flu are estimated to incur annual costs of moreRead more